Navigation Links
ClearCanvas Releases First Commercial Version of Popular Clinical Radiology Workstation; PACS and RIS to Follow
Date:4/15/2011

TORONTO, April 15, 2011 /PRNewswire/ -- ClearCanvas Inc., an innovative medical imaging informatics company, today announced the commercial release of their clinical radiology workstation product, ClearCanvas Workstation, Clinical Edition. This marks the first time ClearCanvas has offered a commercial version of their widely accepted Workstation software, previously only offered as an open source application.

ClearCanvas open source software has been employed for over five years, with more than 14,000 worldwide users in a number of clinical settings. With such extensive application, commercial versions of the products were an obvious next step. ClearCanvas RIS/PACS recently received FDA 510(k) clearance. This important regulatory status allows for commercial distribution of the ClearCanvas software.

The ClearCanvas Workstation, Clinical Edition is available for purchase from the eStore on the ClearCanvas website as well as through a small but rapidly growing number of resellers worldwide.

ClearCanvas expects to release a commercial version of their PACS software suite in Q2 2011 with the commercial release of their RIS following in Q4 2011. Additional versions of the Workstation are already planned for 2011; product upgrades and technical support are included free of charge during the first license year. ClearCanvas will continue to release new versions of their open source software as well.  

"Open source products have always been an integral part of who we are and that will not change," states Norman Young, company President and Founder. "At the same time, we also recognize how important it is to create a vibrant commercial ecosystem by bringing our products to different markets around the world. We are extremely excited to offer what so many of our users have been asking for -- a commercial, FDA-cleared version of our very popular Workstation product."

About ClearCanvas Inc.

ClearCanvas Inc. develops innova
'/>"/>

SOURCE ClearCanvas Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. BioLegend Releases Brilliant Violet 421™ Antibody Conjugates For Advanced Flow Cytometry Applications.
2. ACO Proposed Rule Simplified: MedeAnalytics Releases Comprehensive White Paper
3. Clontech Laboratories, Inc. Releases the SMARTer™ Ultra Low RNA Kit for Illumina® Sequencing
4. OriGene Releases Bioactive Full-length Human MTOR Protein
5. Techne Corporation Releases Unaudited Second Quarter Results for Fiscal Year 2011
6. Waters Releases NuGenesis SDMS 7.1 Validated to Support Windows 7 and Empower 3 CDS
7. OriGene Releases 1500 TrueMAB™ Monoclonal Antibodies
8. ACTE Releases Issue Brief Outlining Critical Role CTE Plays in Worker Retraining
9. Elsevier Releases Image Search; New SciVerse ScienceDirect Feature Enables Researchers to Quickly Find Reliable Visual Content
10. Angiotech Pharmaceuticals, Inc. Releases Selected Projected Financial Information
11. Kibow Biotech Releases Results of Pilot Scale Study of Its Probiotic Formulation for Kidney Health
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2015)... 30, 2015 CASI Pharmaceuticals, Inc. (Nasdaq: ... development and commercialization of innovative therapeutics addressing cancer and ... a commercial focus on China , ... (CFDA) has approved the Company,s application to conduct a ... carcinoma (OCCC) patients for its proprietary drug candidate ENMD-2076.  ...
(Date:3/30/2015)...    Intrexon Corporation (NYSE: XON ... Serono, the biopharmaceutical business of Merck KGaA, Darmstadt, ... exclusive strategic collaboration and license agreement to develop ... therapies. This collaboration advances Merck Serono,s comprehensive, science-driven ... immune system,s natural ability to fight tumors. ...
(Date:3/30/2015)... UK, and BELLINGHAM, Washington, USA (PRWEB) March 29, 2015 ... projects in Europe and the United States and plenary ... highlights planned for SPIE Optics + Optoelectronics ... feature over 700 technical presentations in 17 conferences alongside ... society for optics and photonics , the event will ...
(Date:3/30/2015)... 2015  Naldemedine, an investigational peripherally acting mu-opioid ... Co., Ltd., met its primary and secondary endpoints ... the treatment of opioid-induced constipation (OIC) in adult ... Study results showed that naldemedine (0.2 mg tablet ... of spontaneous bowel movement (SBM) compared with placebo ...
Breaking Biology Technology:CASI Pharmaceuticals Receives Approval From CFDA For Phase 2 Clinical Trial In China With ENMD-2076 For Ovarian Clear Cell Carcinoma 2CASI Pharmaceuticals Receives Approval From CFDA For Phase 2 Clinical Trial In China With ENMD-2076 For Ovarian Clear Cell Carcinoma 3CASI Pharmaceuticals Receives Approval From CFDA For Phase 2 Clinical Trial In China With ENMD-2076 For Ovarian Clear Cell Carcinoma 4CASI Pharmaceuticals Receives Approval From CFDA For Phase 2 Clinical Trial In China With ENMD-2076 For Ovarian Clear Cell Carcinoma 5Intrexon and Merck Serono Announce Agreement for the Development and Commercialization of CAR-T Therapy 2Intrexon and Merck Serono Announce Agreement for the Development and Commercialization of CAR-T Therapy 3Intrexon and Merck Serono Announce Agreement for the Development and Commercialization of CAR-T Therapy 4Laser Energy Advances Among Reports Set for SPIE Optics + Optoelectronics 2Laser Energy Advances Among Reports Set for SPIE Optics + Optoelectronics 3Shionogi & Co., Ltd. Announces That Naldemedine Meets Primary Endpoint In A Phase 3 Study For The Treatment Of Opioid-Induced Constipation 2Shionogi & Co., Ltd. Announces That Naldemedine Meets Primary Endpoint In A Phase 3 Study For The Treatment Of Opioid-Induced Constipation 3
... David B. Samadi, M.D., a world renowned urologic oncologist, discusses his ... techniques spare nerves, tissues, and organs responsible for sexual function and ... surgeries and the results are quite pleasing for his patients. ... ...
... study of Global Methylation with results in half the time ... ... ST. LOUIS, Oct. 30 Sigma-Aldrich (Nasdaq:,SIAL) today introduced ... http://www.sigma-aldrich.com/mdq1 . The,Methylated DNA Quantification Kit employs a familiar ELISA-like ...
... the National Institute of Standards and Technology ... to quickly and cheaply analyze nanoscale dimensions ... Optical Microscope (TSOM) imaging, the technique has ... and biotechnology. , Optical microscopes are not ...
Cached Biology Technology:Prominent Urologist Dr. David B. Samadi Presents Breakthrough Robotic Surgery Techniques on OR Live Webcast 2Prominent Urologist Dr. David B. Samadi Presents Breakthrough Robotic Surgery Techniques on OR Live Webcast 3Prominent Urologist Dr. David B. Samadi Presents Breakthrough Robotic Surgery Techniques on OR Live Webcast 4Sigma-Aldrich Introduces Methylated DNA Quantification Technology for Epigenetic Research 2Sigma-Aldrich Introduces Methylated DNA Quantification Technology for Epigenetic Research 3Nanoscale dimensioning is fast, cheap with new NIST optical technique 2
(Date:3/23/2015)... ANGELES , March 23, 2015  In the ... Federal fraud case conviction losses. This figure accounts for ... which, according to The Nilson Report, exceeds $11 billion ... investigative tool after a crime has occurred. Investor ... and polygraph expert Joe Paolella partnered to ...
(Date:3/20/2015)... Conn. , March 20, 2015 NXT-ID, ... a biometric authentication company focused on the growing mobile ... smart wallet is one of the products featured in ... March 20th at 11:00 PM EST on the DIY ... to Las Vegas , site of ...
(Date:3/17/2015)... Minn. , March 17, 2015 ... technology company specializing in clinical study management systems, ... be in attendance at ARENA,s Outsourcing in Clinical ... NC.  This event provides an excellent forum for ... easy-to-use, flexible and affordable software-as-a-service (SaaS) eClinical technology ...
Breaking Biology News(10 mins):Polygraph Test Now Used to Protect Investors From Fraud 2Polygraph Test Now Used to Protect Investors From Fraud 3NXT-ID's Wocket Biometric Smart Wallet to Air on "I Want That" International CES Special 2NXT-ID's Wocket Biometric Smart Wallet to Air on "I Want That" International CES Special 3Connect With MedNet Solutions At Outsourcing In Clinical Trials Southeast 2
... that an investigational drug (R207910, currently in clinical ... effective at killing latent bacteria. This revelation ... shortened treatments for this globally prevalent disease. ... a serious disease fueled by co-infection of HIV ...
... Fairbanks, Alaska More than 150 scientists are expected to ... of Science Arctic Division conference in Fairbanks, Alaska Sept. ... science and the people of the Arctic. Sessions ... continuing changes in northern regions, as well as on ...
... The chairman of EUS2008 today announced that investigational ... physicians to directly inject malignant tumors with cancer ... presented at the 16th International Symposium of Endoscopic ... This technique, which uses a flexible gastrointestinal endoscope ...
Cached Biology News:Anti-tumor therapy with endoscopic ultrasound may fight cancer more safely and effectively 2
The Holten Horizontal series of laminar airflow work benches offers comfort and ease of use....
The Holten Horizontal series of laminar airflow work benches offers comfort and ease of use....
... Incubated Orbital Shakers combine high durability ... and ease of use. The patented ... the unit to run at high ... unit's class-leading temperature range is delivered ...
Small bottle for hybridization 150 x 35mm...
Biology Products: